iProgen and UBC launches ADC research collaboration to develop novel antibody-PROTAC technology tech@playheads.ca April 1, 2022

iProgen and UBC launches ADC research collaboration to develop novel antibody-PROTAC technology

National Science and Engineering Research Council approves grant to support two-year novel antibody-PROTAC technology research and development. UBC will provide expertise in PROTAC chemistry while iProgen will provide ADC discovery and research expertise.